BRKR faces macro and currency headwinds, but strong BSI Nano growth, AI-driven demand and BioSpin innovations support its long-term outlook.

Bruker’s fair value estimate has been trimmed slightly from US$48.43 to US$47.86 per share, signaling a modest reset in modeled upside. This small move lines up with mixed analyst commentary, where ...

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Strategy ...

On March 27, 2026, Bruker ’s board voted to expand its size to 12 members and appointed Thierry L. Bernard, CEO and Managing Director of QIAGEN N.V., as a Class III director effective April 1, 2026, ...

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones ...

BALTIMORE--(BUSINESS WIRE)-- At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ...

View Bruker Corporation BRKR stock quote prices, financial information, real-time forecasts, and company news from CNN.

The company is tapping the market for at least $600 million in fresh capital. It will use the funds chiefly to retire debt. Just after market close on Tuesday, Bruker announced that it was floating a ...

For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker today announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron ...

GHENT, Belgium--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems.